Impact Factor Collection

 

Endocrine-Related Cancer journal impact factor graphic

Endocrine-Related Cancer’s 2019 Impact Factor has risen to 4.800, with the five-year measure now standing at 5.129.

This increase in Impact Factor reflects the high-quality research identified by the Editorial Board. The journal now ranks 25 out of 143 journals in the Endocrinology and Metabolism category, and 70 out of 244 in the Oncology category.

We extend our thanks profusely to the world-class Editors, authors and reviewers who make the journal what it is, and to Editor-in-Chief Professor Charis Eng for her leadership.

To recognise the new Impact Factor, the Editorial Team has put together a collection of articles that received the most citations in 2019, and contributed to this positive result.

All articles are freely available without subscription.

 

Highly cited in 2019

 

Long noncoding RNAs: emerging players in thyroid cancer pathogenesis
Avaniyapuram Kannan Murugan, Arasambattu Kannan Munirajan and Ali S Alzahrani

Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
Carolyn M Klinge

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial
Marianne Pavel et al.

Anaplastic thyroid carcinoma: review of treatment protocols
Vera Tiedje et al.

Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame
Vincenzo Marotta et al.

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
Tobias Hofving et al.

Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment
Belinda van Zyl, Denise Tang and Nikola A Bowden

miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma
Haleh Vosgha et al.

Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells
Yu-Tang Chin et al.

Treatment of refractory thyroid cancer
Amandine Berdelou et al.

Acquired resistance to aromatase inhibitors: where we stand!
Tiago Vieira Augusto et al.

Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors
Atsuko Kasajima et al.

TERT structural rearrangements in metastatic pheochromocytomas
Trisha Dwight et al.

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours
Johan O Paulsson et al.

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): impact on the reclassification of thyroid nodules
Isabel Amendoeira, Tiago Maia and Manuel Sobrinho-Simões

65 YEARS OF THE DOUBLE HELIX One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine
Lamis Yehia and Charis Eng

8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2)
Livia Lamartina et al.

Neoadjuvant palbociclib on ER plus breast cancer (N007): clinical response and EndoPredict's value
Louis W C Chow et al.

65 YEARS OF THE DOUBLE HELIX Genetics informs precision practice in the diagnosis and management of pheochromocytoma
Hartmut P Neumann et al.